FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281697580> ?p ?o ?g. }

• W4281697580 endingPage "988" @default.
• W4281697580 startingPage "977" @default.
• W4281697580 abstract "It is crucial to economically justify the use of promising therapies such as stereotactic ablative radiotherapy (SABR) for oligometastatic disease (OMD). The goal of this systematic review was to provide a summative evaluation of publications that analyzed the cost-effectiveness (CE) of SABR for OMD. Using Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)-guided methodology, PubMed and Embase were searched for modeling-based CE studies for various forms of limited metastatic disease. Only full publications that specifically compared SABR with a systemic therapy-based approach were included. In total, 9 studies met inclusion criteria; 4 pertained to OMD with mixed histologies, 2 to oligometastatic non-small cell lung cancer, 1 to pulmonary OMD, 1 to liver OMD, and 1 to low-volume oligorecurrent castration-sensitive prostate cancer. All but 1 investigation illustrated that SABR was cost-effective for the studied population (or a subpopulation); of these studies, the incremental CE ratios for SABR (when reported) ranged from $28,000/quality-adjusted life-year (QALY) to $55,000/QALY. Of studies that reported the probability of SABR being cost-effective at common willingness-to-pay values, the median (range) probability of achieving CE was roughly 61% (30%-88%) at a $50,000/QALY threshold and 78% (31%-100%) at a $100,000/QALY threshold. Taken together, the available evidence suggests that SABR appears to be a cost-effective approach for OMD, which has implications for value-based oncologic practice and construction of future health policies. However, reassessment is required in the context of modern systemic therapies (eg, immunotherapy) as well as long-term follow-up of existing and newly reported randomized trials. Prudent patient selection remains the single most important factor influencing the CE of SABR for OMD." @default.
• W4281697580 created "2022-06-13" @default.
• W4281697580 creator A5008781374 @default.
• W4281697580 creator A5044971017 @default.
• W4281697580 creator A5071827540 @default.
• W4281697580 creator A5078248328 @default.
• W4281697580 creator A5084335427 @default.
• W4281697580 creator A5084379902 @default.
• W4281697580 creator A5084574866 @default.
• W4281697580 creator A5085763839 @default.
• W4281697580 date "2022-12-01" @default.
• W4281697580 modified "2023-10-13" @default.
• W4281697580 title "A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer Oligometastases" @default.
• W4281697580 cites W1598788265 @default.
• W4281697580 cites W2007872832 @default.
• W4281697580 cites W2037809152 @default.
• W4281697580 cites W2047947183 @default.
• W4281697580 cites W2128911553 @default.
• W4281697580 cites W2196896782 @default.
• W4281697580 cites W2271996082 @default.
• W4281697580 cites W2282441333 @default.
• W4281697580 cites W2413636075 @default.
• W4281697580 cites W2531269403 @default.
• W4281697580 cites W2763669096 @default.
• W4281697580 cites W2783091042 @default.
• W4281697580 cites W2801587434 @default.
• W4281697580 cites W2886718845 @default.
• W4281697580 cites W2901619788 @default.
• W4281697580 cites W2944301866 @default.
• W4281697580 cites W2973003210 @default.
• W4281697580 cites W2981369656 @default.
• W4281697580 cites W2995444402 @default.
• W4281697580 cites W3019546741 @default.
• W4281697580 cites W3032651552 @default.
• W4281697580 cites W3033718997 @default.
• W4281697580 cites W3084375643 @default.
• W4281697580 cites W3087071367 @default.
• W4281697580 cites W3088107117 @default.
• W4281697580 cites W3159989178 @default.
• W4281697580 cites W3171503272 @default.
• W4281697580 cites W4210289312 @default.
• W4281697580 cites W4291221241 @default.
• W4281697580 doi "https://doi.org/10.1016/j.ijrobp.2022.05.042" @default.
• W4281697580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35675852" @default.
• W4281697580 hasPublicationYear "2022" @default.
• W4281697580 type Work @default.
• W4281697580 citedByCount "1" @default.
• W4281697580 countsByYear W42816975802023 @default.
• W4281697580 crossrefType "journal-article" @default.
• W4281697580 hasAuthorship W4281697580A5008781374 @default.
• W4281697580 hasAuthorship W4281697580A5044971017 @default.
• W4281697580 hasAuthorship W4281697580A5071827540 @default.
• W4281697580 hasAuthorship W4281697580A5078248328 @default.
• W4281697580 hasAuthorship W4281697580A5084335427 @default.
• W4281697580 hasAuthorship W4281697580A5084379902 @default.
• W4281697580 hasAuthorship W4281697580A5084574866 @default.
• W4281697580 hasAuthorship W4281697580A5085763839 @default.
• W4281697580 hasConcept C106159729 @default.
• W4281697580 hasConcept C112930515 @default.
• W4281697580 hasConcept C121608353 @default.
• W4281697580 hasConcept C126322002 @default.
• W4281697580 hasConcept C143998085 @default.
• W4281697580 hasConcept C151730666 @default.
• W4281697580 hasConcept C162324750 @default.
• W4281697580 hasConcept C17744445 @default.
• W4281697580 hasConcept C187625094 @default.
• W4281697580 hasConcept C189708586 @default.
• W4281697580 hasConcept C19527891 @default.
• W4281697580 hasConcept C199539241 @default.
• W4281697580 hasConcept C2779343474 @default.
• W4281697580 hasConcept C2779473830 @default.
• W4281697580 hasConcept C2780192828 @default.
• W4281697580 hasConcept C2908647359 @default.
• W4281697580 hasConcept C3019080777 @default.
• W4281697580 hasConcept C509974204 @default.
• W4281697580 hasConcept C64332521 @default.
• W4281697580 hasConcept C71924100 @default.
• W4281697580 hasConcept C85393063 @default.
• W4281697580 hasConcept C86803240 @default.
• W4281697580 hasConcept C91602232 @default.
• W4281697580 hasConcept C99454951 @default.
• W4281697580 hasConceptScore W4281697580C106159729 @default.
• W4281697580 hasConceptScore W4281697580C112930515 @default.
• W4281697580 hasConceptScore W4281697580C121608353 @default.
• W4281697580 hasConceptScore W4281697580C126322002 @default.
• W4281697580 hasConceptScore W4281697580C143998085 @default.
• W4281697580 hasConceptScore W4281697580C151730666 @default.
• W4281697580 hasConceptScore W4281697580C162324750 @default.
• W4281697580 hasConceptScore W4281697580C17744445 @default.
• W4281697580 hasConceptScore W4281697580C187625094 @default.
• W4281697580 hasConceptScore W4281697580C189708586 @default.
• W4281697580 hasConceptScore W4281697580C19527891 @default.
• W4281697580 hasConceptScore W4281697580C199539241 @default.
• W4281697580 hasConceptScore W4281697580C2779343474 @default.
• W4281697580 hasConceptScore W4281697580C2779473830 @default.
• W4281697580 hasConceptScore W4281697580C2780192828 @default.
• W4281697580 hasConceptScore W4281697580C2908647359 @default.
• W4281697580 hasConceptScore W4281697580C3019080777 @default.

• next